BCRX
Congressional ActivityBioCryst Pharmaceuticals, Inc. -
Common Stock (BCRX) [ST]
ARIA INTELLIGENCE BRIEF
Disclosure records for this Health Care sector security show a modest congressional trading footprint, with two members — Josh Gottheimer and Gil Cisneros — accounting for all three disclosed transactions between September 2023 and November 2025. The balance tilts toward buying, with two purchases against one sale across that period. No bipartisan co-trading clusters are recorded for this name, and no executive-branch officials have disclosed transactions in the security within the public filing record.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
3
BUYS
2
SELLS
1
MEMBERS
2
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
-9.46%
vs SPY benchmark
BCRX timeline3 trades · Congress · single source
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
No OGE 278-T disclosures found for BCRX.
3 trades
Congressional trading data from STOCK Act filings. Not investment advice.